|Articles|April 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Coronary Heart Disease: A Managed Care Approach
- Volume 4
- Issue 4 Suppl
Point/Counterpoint: Is LDL-C Reduction the Outcome of Choice?
Advertisement
Articles in this issue
about 28 years ago
Participating Facultyabout 28 years ago
Coronary Heart Disease in the United Statesabout 28 years ago
Mechanisms of Acute Coronary Eventsabout 28 years ago
Primary Preventionabout 28 years ago
Pravastatin Event Reduction Analysisabout 28 years ago
Secondary Preventionabout 28 years ago
Methods and Mindsets in Pharmacoeconomicsabout 28 years ago
Issues and Controversies in Pharmacoeconomicsabout 28 years ago
Pharmacoeconomics Perspectives: Payers, Providers, and PatientsAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
ATTR-CM Incidence, Prevalence Rose Sharply in the US
2
Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC
3
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
4
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
5